Citations (41)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Aurore Bergamasco, Nadine Hartmann, Laura Wallace & Patrice Verpillat. (2019) Epidemiology of systemic sclerosis and systemic sclerosis-associated interstitial lung disease. Clinical Epidemiology 11, pages 257-273.
Read now
Read now
Joyce S. Lee & Aryeh Fischer. (2016) Current and emerging treatment options for interstitial lung disease in patients with rheumatic disease. Expert Review of Clinical Immunology 12:5, pages 509-520.
Read now
Read now
Richard H Gomer & Mark L Lupher$suffix/text()$suffix/text(). (2010) Investigational approaches to therapies for idiopathic pulmonary fibrosis. Expert Opinion on Investigational Drugs 19:6, pages 737-745.
Read now
Read now
Articles from other publishers (38)
Demitrios Dedousis, Annie L. Zhang, Anastasia N. Vassiliou, Shufen Cao, Deepthi Yammani, Ravi K. Kyasaram, John P. Shanahan, Melissa C. Keinath, Melinda L. Hsu, Pingfu Fu, Afshin Dowlati & Alberto J. Montero. (2023) Survival in elderly patients with breast cancer with and without autoimmune disease. Cancer Medicine 12:12, pages 13086-13099.
Crossref
Crossref
Ada Man, M. Kari Connolly & Robert W. Simms. 2022. Interdisciplinary Approaches to Overlap Disorders in Dermatology & Rheumatology. Interdisciplinary Approaches to Overlap Disorders in Dermatology & Rheumatology
107
135
.
Eric Y. Yen, Devanshu R. Singh & Ram R. Singh. (2021) Trends in Systemic Sclerosis Mortality Over Forty‐Eight Years, 1968–2015: A US Population–Based Study. Arthritis Care & Research 73:10, pages 1502-1510.
Crossref
Crossref
Majd Bairkdar, Marios Rossides, Helga Westerlind, Roger Hesselstrand, Elizabeth V Arkema & Marie Holmqvist. (2021) Incidence and prevalence of systemic sclerosis globally: a comprehensive systematic review and meta-analysis. Rheumatology 60:7, pages 3121-3133.
Crossref
Crossref
Qiang Li, Laura Wallace, Padmaja Patnaik, Margarida Alves, Martina Gahlemann, Veronika Kohlbrenner, Christina Raabe, Jocelyn R Wang & Elizabeth M Garry. (2021) Disease frequency, patient characteristics, comorbidity outcomes and immunosuppressive therapy in systemic sclerosis and systemic sclerosis-associated interstitial lung disease: a US cohort study. Rheumatology 60:4, pages 1915-1925.
Crossref
Crossref
Alexandra Balbir-Gurman & Yolanda Braun-Moscovici. 2021. Practical Management of Systemic Sclerosis in Clinical Practice. Practical Management of Systemic Sclerosis in Clinical Practice
55
66
.
Yanni FanShaun BenderWeizhi ShiDonald Zoz. (2020) Incidence and prevalence of systemic sclerosis and systemic sclerosis with interstitial lung disease in the United States. Journal of Managed Care & Specialty Pharmacy 26:12, pages 1539-1547.
Crossref
Crossref
Mislav Radic & Tracy M Frech. (2020) Big data in systemic sclerosis: Great potential for the future. Journal of Scleroderma and Related Disorders 5:3, pages 172-177.
Crossref
Crossref
David Ying, Milena A. Gianfrancesco, Laura Trupin, Jinoos Yazdany, Eric L. Greidinger & Gabriela Schmajuk. (2020) Increased Risk of Ischemic Stroke in Systemic Sclerosis: A National Cohort Study of US Veterans. The Journal of Rheumatology 47:1, pages 82-88.
Crossref
Crossref
Lixian Zhong, Melinda Pope, Ye Shen, Jose J. Hernandez & Lin Wu. (2019) Prevalence and incidence of systemic sclerosis: A systematic review and meta‐analysis. International Journal of Rheumatic Diseases 22:12, pages 2096-2107.
Crossref
Crossref
Khalaf Kridin, Dana Tzur Bitan, Doron Comaneshter & Arnon D. Cohen. (2019) The prevalence of systemic sclerosis is increased among patients with alopecia areata: a population-based study. Immunologic Research 67:4-5, pages 368-372.
Crossref
Crossref
Nicola L. Bragazzi, Abdulla Watad, Alex Gizunterman, Dennis McGonagle, Hussein Mahagna, Doron Comaneshter, Howard Amital, Arnon D. Cohen & Daniela Amital. (2019) The burden of depression in systemic sclerosis patients: a nationwide population-based study. Journal of Affective Disorders 243, pages 427-431.
Crossref
Crossref
Abdulla Watad, Nicola Luigi Bragazzi, Francesco Brigo, Mohammad Adawi, Naim Mahroum, Doron Comaneshter, Daniela Amital, Arnon D. Cohen & Howard Amital. (2018) Epilepsy is not statistically associated with systemic sclerosis but significantly impacts on mortality: A real-world epidemiological survey-based study. Best Practice & Research Clinical Rheumatology 32:5, pages 710-717.
Crossref
Crossref
Abdulla Watad, Nicola L. Bragazzi, Shmuel Tiosano, Yarden Yavne, Doron Comaneshter, Arnon D. Cohen & Howard Amital. (2018) Alzheimer’s Disease in Systemic Sclerosis Patients: A Nationwide Population-Based Cohort Study. Journal of Alzheimer's Disease 65:1, pages 117-124.
Crossref
Crossref
Begoña Marí-Alfonso, Carmen Pilar Simeón-Aznar, Alfredo Guillén-Del Castillo, Manuel Rubio-Rivas, Luis Trapiella-Martínez, José Antonio Todolí-Parra, Mónica Rodríguez Carballeira, Adela Marín-Ballvé, Nerea Iniesta-Arandia, Dolores Colunga-Argüelles, María Jesús Castillo-Palma, Luis Sáez-Comet, María Victoria Egurbide-Arberas, Norberto Ortego-Centeno, Mayka Freire, José Antonio Vargas Hitos, Antonio-J Chamorro, Ana Belen Madroñero-Vuelta, Isabel Perales-Fraile, Xavier Pla-Salas, Rafael A. Fernández-De-La-Puebla, Vicent Fonollosa-Pla & Carles Tolosa-Vilella. (2018) Hepatobiliary involvement in systemic sclerosis and the cutaneous subsets: Characteristics and survival of patients from the Spanish RESCLE Registry. Seminars in Arthritis and Rheumatism 47:6, pages 849-857.
Crossref
Crossref
G.W. Kang, K.H. Jung, Y.S. Lee, H.J. Kim, D.Y. Yoon, S.H. Lee, H.J. Hann, K.H. Kim, S. Han, Y. Kim, D.S. Kim & H.S. Ahn. (2017) Incidence, prevalence, mortality and causes of death in systemic sclerosis in Korea: a nationwide population‐based study. British Journal of Dermatology 178:1.
Crossref
Crossref
Edward V. Lally, Ami A. Shah & Fredrick M. Wigley. 2017. Scleroderma. Scleroderma
533
550
.
Jammie K. Barnes, Luc Mouthon & Maureen D. Mayes. 2017. Scleroderma. Scleroderma
11
24
.
Dinesh Khanna, Jörg H.W. Distler, Peter Sandner & Oliver Distler. (2016) Emerging strategies for treatment of systemic sclerosis. Journal of Scleroderma and Related Disorders 1:2, pages 186-193.
Crossref
Crossref
Paolo Spagnolo, Jean-François Cordier & Vincent Cottin. (2016) Connective tissue diseases, multimorbidity and the ageing lung. European Respiratory Journal 47:5, pages 1535-1558.
Crossref
Crossref
Chia-Chun Tseng, Shun-Jen Chang, Wen-Chan Tsai, Tsan-Teng Ou, Cheng-Chin Wu, Wan-Yu Sung, Ming-Chia Hsieh & Jeng-Hsien Yen. (2016) Increased incidence of multiple sclerosis in systemic sclerosis: A nationwide cohort study. Preventive Medicine 84, pages 6-11.
Crossref
Crossref
Chia-Chun Tseng, Jeng-Hsien Yen, Wen-Chan Tsai, Tsan-Teng Ou, Cheng-Chin Wu, Wan-Yu Sung, Ming-Chia Hsieh & Shun-Jen Chang. (2015) Reduced incidence of Crohn’s disease in systemic sclerosis: a nationwide population study. BMC Musculoskeletal Disorders 16:1.
Crossref
Crossref
Edoardo Savarino, Manuele Furnari, Nicola de Bortoli, Irene Martinucci, Giorgia Bodini, Massimo Ghio & Vincenzo Savarino. (2014) Gastrointestinal involvement in systemic sclerosis. La Presse Médicale 43:10, pages e279-e291.
Crossref
Crossref
Avram Goldberg, Thomas Geppert, Elena Schiopu, Tracy Frech, Vivien Hsu, Robert W Simms, Stanford L Peng, Yihong Yao, Nairouz Elgeioushi, Linda Chang, Bing Wang & Stephen Yoo. (2014) Dose-escalation of human anti-interferon-α receptor monoclonal antibody MEDI-546 in subjects with systemic sclerosis: a phase 1, multicenter, open label study. Arthritis Research & Therapy 16:1, pages R57.
Crossref
Crossref
Tiago Nardi Amaral, Fernando Augusto Peres, Aline Tamires Lapa, João Francisco Marques-Neto & Simone Appenzeller. (2013) Neurologic involvement in scleroderma: A systematic review. Seminars in Arthritis and Rheumatism 43:3, pages 335-347.
Crossref
Crossref
Haritina El Adssi, Daniela Cirstea, Jean-Marc Virion, Francis Guillemin & Jean-Dominique de Korwin. (2013) Estimating the Prevalence of Systemic Sclerosis in the Lorraine Region, France, by the Capture–recapture Method. Seminars in Arthritis and Rheumatism 42:5, pages 530-538.
Crossref
Crossref
Ami A. Shah & Fredrick M. Wigley. (2013) My Approach to the Treatment of Scleroderma. Mayo Clinic Proceedings 88:4, pages 377-393.
Crossref
Crossref
DANIEL E. FURST, ANCILLA W. FERNANDES, SERBAN R. IORGA, WARREN GRETH & TIM BANCROFT. (2012) Annual Medical Costs and Healthcare Resource Use in Patients with Systemic Sclerosis in an Insured Population. The Journal of Rheumatology 39:12, pages 2303-2309.
Crossref
Crossref
DANIEL E. FURST, ANCILLA W. FERNANDES, ŞERBAN R. IORGA, WARREN GRETH & TIM BANCROFT. (2012) Epidemiology of Systemic Sclerosis in a Large US Managed Care Population. The Journal of Rheumatology 39:4, pages 784-786.
Crossref
Crossref
R. Li, J. Sun, L.-M. Ren, H.-Y. Wang, W.-H. Liu, X.-W. Zhang, S. Chen, R. Mu, J. He, Y. Zhao, L. Long, Y.-Y. Liu, X. Liu, X.-L. Lu, Y.-H. Li, S.-Y. Wang, S.-S. Pan, C. Li, H.-Y. Wang & Z.-G. Li. (2011) Epidemiology of eight common rheumatic diseases in China: a large-scale cross-sectional survey in Beijing. Rheumatology 51:4, pages 721-729.
Crossref
Crossref
Ami A. Shah. 2012. Scleroderma. Scleroderma
559
568
.
Jammie K. Barnes & Maureen D. Mayes. 2012. Scleroderma. Scleroderma
17
28
.
Cheryl Barnabe, Lawrence Joseph, Patrick Belisle, Jeremy Labrecque, Steven Edworthy, Susan G. Barr, Marvin Fritzler, Lawrence W. Svenson, Brenda Hemmelgarn & Sasha Bernatsky. (2012) Prevalence of systemic lupus erythematosus and systemic sclerosis in the First Nations population of Alberta, Canada. Arthritis Care & Research 64:1, pages 138-143.
Crossref
Crossref
Rebecca L MannoLaura K Hummers. (2011) Aging and scleroderma. Aging Health 7:2, pages 231-242.
Crossref
Crossref
Zachary D. McCormic, Sura S. Khuder, Bishwa K. Aryal, April L. Ames & Sadik A. Khuder. (2010) Occupational silica exposure as a risk factor for scleroderma: a meta-analysis. International Archives of Occupational and Environmental Health 83:7, pages 763-769.
Crossref
Crossref
Brigitte Ranque & Luc Mouthon. (2010) Geoepidemiology of systemic sclerosis. Autoimmunity Reviews 9:5, pages A311-A318.
Crossref
Crossref
Glinda S. Cooper, Milele L.K. Bynum & Emily C. Somers. (2009) Recent insights in the epidemiology of autoimmune diseases: Improved prevalence estimates and understanding of clustering of diseases. Journal of Autoimmunity 33:3-4, pages 197-207.
Crossref
Crossref
MARIE HUDSON, ANISH SHARMA, JESSICA BERNSTEIN & MURRAY BARON. (2009) Validity of Self-Reported Comorbidities in Systemic Sclerosis: Table 1.. The Journal of Rheumatology 36:7, pages 1477-1480.
Crossref
Crossref